Breaking Down Why Medicare Part D Premiums Are Likely To Go Up
Insurers will take drug costs, frequency of use, and other factors into account as they set premium amounts for the 2026 plan year.
Drug Costs
41-60 of 711 results
-
-
Why Young Americans Dread Turning 26: Health Insurance Chaos
Young adults without jobs that provide insurance find their options are limited and expensive. The problem is about to get worse.
By Elisabeth Rosenthal and Hannah Norman -
A Guide To Finding Insurance at 26
It’s a difficult rite of passage for young adults without job-based insurance. Here are some tips for getting started.
Kennedy Cancels Vaccine Funding
Episode 409The Health and Human Services secretary is winding down nearly $500 million in mRNA research funding, citing false claims that the technology is ineffective against respiratory illnesses — and notching a victory for critics of the covid vaccines. And President Donald Trump is demanding drugmakers drop their prices, quickly, but it’s unclear how he could make them comply. Lauren Weber of The Washington Post, Sandhya Raman of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Emmarie Huetteman to discuss these stories and more.
-
A Tourist Ended Up With a Wild Bat in Her Mouth — And Nearly $21,000 in Medical Bills
Health insurance generally doesn’t cover treatment for injuries sustained shortly before a customer buys a policy. A Massachusetts woman found that out the hard way.
By Tony Leys The Prescription Drug Playbook, Part II
Season 13, Episode 10In this second part of a two-part series on dealing with the high price of prescription drugs, experts share their insider tips.
The Prescription Drug Playbook, Part I
Season 13, Episode 9In Part 1 of a two-part series on dealing with the high price of prescription drugs, a father explains the strategies he used to get his daughter the medicine she needs to treat her epilepsy.
-
Trump Exaggerates Speed and Certainty of Prescription Drug Price Reductions
According to the timeline in the May 12 executive order, prescription drug price reductions would not happen "almost immediately,” but rather could take months or years. And extending the savings to Americans outside federal health insurance programs such as Medicare would likely require congressional action.
-
Journalists Unpack Drug Prices, Threats to Medicaid, and the Fluoridation of Water
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
-
Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs
While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account for 90% of U.S. prescriptions — see trouble ahead for patients.
By Jackie Fortiér and Arthur Allen GOP Tries To Cut Billions in Health Benefits
Episode 397GOP-controlled House committees approved parts of President Donald Trump’s “one big, beautiful bill” this week, including more than $700 billion in cuts to health programs over the next decade — mostly from Medicaid, which covers people with low incomes or disabilities. Meanwhile, Health and Human Services Secretary Robert F. Kennedy Jr. testified before Congress for the first time since taking office and told lawmakers that Americans shouldn’t take medical advice from him. Julie Appleby of KFF Health News, Alice Miranda Ollstein of Politico, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News’ Julie Rovner to discuss these stories and more.
Cutting Medicaid Is Hard — Even for the GOP
Episode 396Republicans on Capitol Hill are struggling to reach consensus on cutting the Medicaid program as they search for nearly a trillion dollars in savings over the next decade — as many observers predicted. Meanwhile, turmoil continues at the Department of Health and Human Services, with more controversial cuts and personnel moves, including the sudden nomination of Casey Means, an ally of Robert F. Kennedy Jr.’s, to become surgeon general. Anna Edney of Bloomberg News, Maya Goldman of Axios, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Lauren Sausser, who co-reported the latest “Bill of the Month” feature, about an unexpected bill for what seemed like preventive care.
On Autism, It’s the Secretary’s Word vs. the CDC’s
Episode 393Tensions between Robert F. Kennedy Jr. and his employees at the Department of Health and Human Services are mounting, as he made a series of claims about autism this week — contradicting his agency’s findings. Plus, President Donald Trump unveiled an executive order to lower drug prices as his administration explores tariffs that could raise them. Shefali Luthra of The 19th, Jessie Hellmann of CQ Roll Call, and Anna Edney of Bloomberg News join KFF Health News’ Emmarie Huetteman to discuss these stories and more. Plus, KFF Health News’ Julie Rovner interviews two University of California-San Francisco researchers about an upcoming Supreme Court case that could have major ramifications for preventive care.
American Health Gets a Pink Slip
Episode 391The Department of Health and Human Services underwent an unprecedented purge this week, as thousands of employees from the National Institutes of Health, the FDA, the Centers for Disease Control and Prevention, and other agencies were fired, placed on administrative leave, or offered transfers to far-flung Indian Health Service facilities. Altogether, the layoffs mean the federal government, in a single day, shed hundreds if not thousands of combined years of health and science expertise. Lauren Weber of The Washington Post, Rachel Cohrs Zhang of Bloomberg News, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Julie Rovner to discuss this enormous breaking story and more. Also this week, Rovner interviews KFF Health News’ Julie Appleby, who reported and wrote the latest “Bill of the Month” feature about a short-term health plan and a very expensive colonoscopy.
-
Montana’s Small Pharmacies Behind Bill To Corral Pharmacy Benefit Managers
A bill designed to force PBMs to pay higher fees to independent drugstores sailed through the state House, but lobbyists are marshaling their forces to kill the measure in the Senate.
Federal Health Work in Flux
Episode 389It’s the Trump administration vs. the federal courts, as the Department of Government Efficiency continues to try to cancel federal contracts and programs and fire workers. But in the haste to cut things, jobs and programs are being eliminated even if they align with the new administration’s goal to “Make America Healthy Again.” Jessie Hellmann of CQ Roll Call, Sarah Karlin-Smith of the Pink Sheet, and Rachel Roubein of The Washington Post join KFF Health News’ Julie Rovner to discuss these stories and more.
-
Years Later, Centene Settlements With States Still Unfinished
At least 20 states have settled disputes with health insurance giant Centene since 2021 over allegations that its pharmacy benefit manager operation overcharged their Medicaid programs. Two holdouts appear to remain: Georgia has not yet settled, and Florida officials won’t answer questions about its Centene situation.
By Andy Miller -
Republicans Once Wanted Government out of Health Care. Trump Voters See It Differently.
Frustrated by high health care prices, many who backed President Donald Trump support strong government actions to protect patients. It’s unclear whether GOP leaders will listen.
-
Top California Democrats Clash Over How To Rein In Drug Industry Middlemen
Frustrated by spiraling drug costs, California lawmakers want to increase oversight of pharmaceutical industry intermediaries known as pharmacy benefit managers. It’s unclear whether they can persuade Gov. Gavin Newsom to get on board.
How Do You Deal With Wild Drug Prices?
Season 13, Episode 2“An Arm and a Leg” is collecting stories for a new series about how Americans get the medicine they need when faced with sticker shock.